Table 3.
The association between BDH1 mRNA expression, other clinical parameters, and liver cancer patient overall survival.
| Univariate analysis | Multivariate analysis | |||||
| Parameters | Hazard ratio | 95%CI (lower∼upper) | P value | Hazard ratio | 95%CI (lower-upper) | P value |
| Age | 1.00 | 0.69–1.45 | .997 | |||
| Gender | 0.80 | 0.56–1.14 | .220 | |||
| Histological type | 0.99 | 0.27–3.66 | .986 | |||
| Histologic grade | 1.04 | 0.84–1.3 | .698 | |||
| Stage | 1.38 | 1.15–1.66 | .001 | 0.86 | 0.7–1.07 | .183 |
| T classification | 1.66 | 1.39–1.99 | .000 | 1.74 | 1.38–2.19 | .000 |
| N classification | 0.73 | 0.51–1.05 | .086 | |||
| M classification | 0.72 | 0.49–1.04 | .077 | |||
| Radiation therapy | 0.51 | 0.26–1.03 | .060 | |||
| Residual Tumor | 1.42 | 1.13–1.8 | .003 | 1.39 | 1.08–1.78 | .009 |
| BDH1 | 2.02 | 1.37–2.96 | .000 | 1.60 | 1.08–2.38 | .020 |